Pharmaceutical Business Review
The treatment targets adult patients with ES-SCLC who have experienced disease progression on or after platinum-based chemotherapy.
Pharmaceutical Business Review
The treatment targets adult patients with ES-SCLC who have experienced disease progression on or after platinum-based chemotherapy.
Pharmaceutical Business Review
The treatment targets adult patients with ES-SCLC who have experienced disease progression on or after platinum-based chemotherapy.